4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-014541
Options or other derivatives
- Chief Development Officer acquired 52,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TURKEL CATHERINE C. Chief Development Officer | 2017-05-24 | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | D | ||
Loading xslF345X03/doc4.xml…